Coronary Artery Calcium Scans Offer Limited Benefit for Most Patients, New Northwestern Medicine Study Finds

Coronary artery calcium (CAC) scans have surged in popularity over the past decade as a fast, non-invasive, and relatively affordable diagnostic method for assessing an individual’s future vulnerability to cardiovascular disease. Utilizing computed tomography (CT) technology, these scans measure the accumulation of calcified plaque within the coronary arteries—the vital vessels responsible for supplying oxygen-rich blood to the heart muscle. For years, patients and physicians alike have turned to these scans to peer into the cardiovascular future, hoping to catch early warning signs of heart attacks and strokes before symptoms manifest.

However, groundbreaking research recently published by a team of scientists at Northwestern Medicine suggests that the utility of these scans may be far more restricted than previously believed. Rather than serving as a universal screening tool for the general public, the study indicates that CAC scans provide their most profound and clinically meaningful benefit to a relatively narrow band of patients—specifically those whose baseline risk profile sits in a gray area.

The findings, published on August 26 in the Journal of the American Medical Association (JAMA), call for a more nuanced approach to cardiovascular screening. As healthcare systems grapple with rising costs and the need to optimize resource allocation, this study prompts a re-evaluation of routine preventive cardiology practices, emphasizing precision medicine over broad, generalized screening initiatives.

Methodology and Findings: Tracking Health Outcomes Over a Decade

To evaluate the true incremental value of coronary artery calcium scans, the research team—led by senior author Dr. Nilay Shah, assistant professor of medicine in the division of cardiology at the Northwestern University Feinberg School of Medicine—analyzed extensive longitudinal data from the landmark Multi-Ethnic Study of Atherosclerosis (MESA).

The study cohort comprised more than 6,000 diverse adults aged 45 to 79 who were free of clinical cardiovascular disease at baseline. At the onset of the research period, each participant underwent a baseline coronary artery calcium scan to determine their numerical calcium score. Simultaneously, researchers calculated each individual’s predicted 10-year risk of cardiovascular events using PREVENT, the American Heart Association’s primary and highly sophisticated cardiovascular risk calculator.

PREVENT operates by synthesizing standard, easily accessible clinical metrics—such as blood pressure, total cholesterol levels, age, sex, and other foundational health indicators—to forecast the statistical probability of a heart attack or stroke occurring within a 10- or 30-year timeframe.

Following these baseline assessments, the researchers tracked the participants’ health trajectories over a 10-year period to observe real-world cardiovascular outcomes. During this decade of observation, approximately 6% of the study population experienced a definitive cardiovascular event, such as a non-fatal heart attack or stroke.

When the research team compared predictive models that incorporated the calcium scores against models relying exclusively on the PREVENT calculator, the results revealed a surprising reality. For the broad study population as a whole, adding the calcium score provided only a marginal enhancement in predictive accuracy. Specifically, the statistical model’s discrimination—a measure of how effectively a tool distinguishes between individuals who will experience an event and those who will not—rose only slightly, moving from 0.73 using PREVENT alone to 0.75 when calcium scores were integrated.

The Sweet Spot: Clarifying Borderline and Intermediate Risk Categories

While the broad population-level improvement was modest, the narrative shifted dramatically when the researchers isolated specific risk strata. When the team focused exclusively on participants whose initial PREVENT scores placed them in the borderline or intermediate risk categories—defined as individuals with an estimated 3% to 9% risk of developing heart disease over the subsequent decade—the inclusion of the calcium score yielded a clinically meaningful improvement in risk stratification.

For patients trapped in this diagnostic middle ground, the CT scan acted as a clinical tiebreaker. A zero calcium score often down-rated a patient’s true biological risk, reassuring both the physician and the patient that aggressive pharmacological intervention might be safely deferred. Conversely, a high calcium score escalated the perceived risk, signaling that intensive preventive measures were urgently required.

"For patients at borderline risk, knowing their calcium score can help determine whether their risk is actually lower or higher than initially estimated, which can help guide treatment decisions," explained Dr. Shah. This targeted utility suggests that the scan is most powerful when uncertainty is highest, serving as a precision tool rather than a routine check-up add-on.

Clinical Implications: Weighing the Risks and Costs of Over-Testing

The publication of the Northwestern study comes at a critical juncture for modern preventative medicine. As diagnostic imaging becomes more accessible, the temptation to order supplementary tests "just to be safe" has grown among both clinicians and health-conscious consumers. However, Dr. Shah and his co-authors caution that indiscriminate scanning carries tangible downsides.

For individuals who fall into low-risk categories based on standard evaluations like PREVENT, the addition of a calcium scan is largely redundant. Routine scanning in low-risk populations exposes patients to unnecessary ionizing radiation—albeit a relatively low dose—along with the financial burden of out-of-pocket testing costs and the cascade of anxiety and follow-up procedures triggered by incidental findings.

On the other end of the spectrum, individuals categorized as high risk based on traditional health metrics already clear the clinical threshold for aggressive intervention. Current medical guidelines recommend that high-risk individuals initiate statin therapy to lower cholesterol and reduce cardiovascular events, regardless of whether a calcium scan detects calcified plaque. Consequently, ordering a scan for a high-risk patient is clinically redundant, adding unnecessary medical expenditure without altering the fundamental treatment plan.

"Routinely using a calcium scan in people who are at low risk may result in unnecessary radiation exposure, testing and costs with unclear clinical benefits," Dr. Shah noted. "Using calcium scans in people who are at high risk is likely to result in unnecessary testing because these individuals are recommended to start a statin regardless of what the calcium scan shows."

Validating the PREVENT Calculator

Beyond its evaluation of calcium scans, the study also serves as a robust validation of the American Heart Association’s PREVENT algorithm. The findings demonstrate that even when deployed in isolation—unaccompanied by advanced imaging data—the PREVENT calculator performs exceptionally well in estimating long-term cardiovascular risk.

Cardiovascular disease remains the leading cause of mortality in the United States, accounting for approximately one in every five deaths and affecting roughly 10% of American adults aged 30 to 79. Because many of these life-threatening events are preventable through early lifestyle modifications and timely pharmacological treatments like statins, accurate risk assessment is the cornerstone of modern cardiology. The data from the MESA cohort reassure the medical community that foundational risk calculators remain powerful, reliable instruments in primary care settings.

Limitations and Horizons for Future Research

While the study offers profound insights into cardiovascular screening, the research team acknowledges several inherent limitations that point toward necessary future investigations.

First, the demographic composition of the MESA study, while ethnically diverse, leaves open questions regarding how these predictive models perform in specific ethnic groups not fully captured or analyzed in granular detail. Dr. Shah pointed out that higher-risk demographic cohorts—such as South Asian and Filipino populations, which often exhibit unique cardiovascular risk profiles—require dedicated study to determine the exact value of integrating calcium scores with PREVENT equations.

Additionally, because the study participants were between the ages of 45 and 79 at baseline, further research is required to understand the utility of these tools in younger adult populations. As early-onset cardiovascular disease becomes an increasing concern for public health officials, determining the optimal screening age for both risk calculators and imaging modalities remains an urgent priority.

Broader Impact on Healthcare Policy and Clinical Practice

The implications of the Northwestern Medicine study extend far beyond academic cardiology journals, touching upon healthcare economics, clinical guidelines, and patient advocacy. In an era where healthcare systems are increasingly focused on value-based care, eliminating low-value diagnostic imaging is paramount. By demonstrating that calcium scans offer diminishing returns outside of specific risk thresholds, the research provides a clear framework for clinicians seeking to optimize patient care pathways.

Medical societies and insurance providers may utilize these findings to refine coverage policies and clinical guidelines, steering physicians toward a more methodical, risk-stratified approach. Rather than adopting a blanket philosophy of "scan everyone," healthcare providers are encouraged to perform thorough baseline risk assessments using tools like PREVENT first, reserving imaging technologies for patients where clinical uncertainty genuinely impacts therapeutic decision-making.

Ultimately, the study reinforces the principle that more data is not always better data. In the complex landscape of cardiovascular disease prevention, precision, timing, and appropriate patient selection remain the ultimate determinants of successful clinical outcomes.

Additional co-authors from Northwestern University Feinberg School of Medicine contributing to the study include Xiaoning Huang, Lucia Petito, Norrina Allen, Dr. Philip Greenland, and Dr. Sadiya Khan.

The research was officially titled "Predictive Utility of Coronary Artery Calcium Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations" and received financial backing from the American Heart Association under grant 24CDA1266732, alongside comprehensive support from the National Heart, Lung, and Blood Institute through multiple federal research contracts.